Shared Care Guidance for Tagraxofusp Treatment in BPDCN

figshare admin karger published a 1.4 MB DOCX file on 2026-06-02. This document is a review article providing best-practice guidance for implementing a shared-care model for tagraxofusp, the only approved treatment for blastic plasmacytoid dendritic cell neoplasm (BPDCN). It discusses patient selection, institutional readiness, and collaborative management strategies.

Use Cases

• Developing institutional protocols for shared-care oncology treatments based on the described best practices.
• Educating clinical staff on managing tagraxofusp administration and adverse events based on the review's key messages.
• Structuring patient and caregiver education programs for BPDCN treatment based on the guidance provided.
• Researching care coordination frameworks for targeted cancer therapies based on the discussed model.

Strengths

• File size is precisely 1.4 MB.
• License is clearly defined as CC-BY-4.0.
• Last update timestamp is provided (2026-06-02 07:55:09).

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is a single 1.4 MB document, limiting scale for quantitative analysis.

Provenance

Source

figshare admin karger

Collection Method

Likely a published medical review article uploaded to figshare.

Freshness

Last updated 2026-06-02 07:55:09; freshness should be verified.